2,683
Views
36
CrossRef citations to date
0
Altmetric
Extra View

Oncogene dependent requirement of fatty acid synthase in hepatocellular carcinoma

, , , , , , , , & show all
Pages 499-507 | Received 09 Dec 2016, Accepted 10 Jan 2017, Published online: 01 Mar 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Poonam Parashar, Preeti Rana, Monika Dwivedi & Shubhini A Saraf. (2019) Dextrose modified bilosomes for peroral delivery: improved therapeutic potential and stability of silymarin in diethylnitrosamine-induced hepatic carcinoma in rats. Journal of Liposome Research 29:3, pages 251-263.
Read now

Articles from other publishers (34)

Kristy Kwan-Shuen Chan, Kwan-Yung Au, Long-Hin Suen, Bernice Leung, Cheuk-Yan Wong, Wei-Qiang Leow, Tony Kiat-Hon Lim, Irene Oi-Lin Ng, Clive Yik-Sham Chung & Regina Cheuk-Lam Lo. (2023) Sortilin-Driven Cancer Secretome Enhances Tumorigenic Properties of Hepatocellular Carcinoma via de Novo Lipogenesis. The American Journal of Pathology 193:12, pages 2156-2171.
Crossref
Flora Yang, Leena Hilakivi-Clarke, Aurpita Shaha, Yuanguo Wang, Xianghu Wang, Yibin Deng, Jinping Lai & Ningling Kang. (2023) Metabolic reprogramming and its clinical implication for liver cancer. Hepatology 78:5, pages 1602-1624.
Crossref
Stephanie Talamantes, Michela Lisjak, Eduardo H. Gilglioni, Camilo J. Llamoza-Torres, Bruno Ramos-Molina & Esteban N. Gurzov. (2023) Non-alcoholic fatty liver disease and diabetes mellitus as growing aetiologies of hepatocellular carcinoma. JHEP Reports 5:9, pages 100811.
Crossref
Dimitri Vanauberg, Céline Schulz & Tony Lefebvre. (2023) Involvement of the pro-oncogenic enzyme fatty acid synthase in the hallmarks of cancer: a promising target in anti-cancer therapies. Oncogenesis 12:1.
Crossref
Plabon Kumar Das, Joti Saha, Suja Pillai, Alfred K.‐Y. Lam, Vinod Gopalan & Farhadul Islam. (2022) Implications of estrogen and its receptors in colorectal carcinoma. Cancer Medicine 12:4, pages 4367-4379.
Crossref
Wentao Luo, Yaxue Huang, Xiuxiu Qiu, Wenxiao Zhuo, Yujun Tao, Shuaiyang Wang, Huaixia Li, Jing Shen, Lelin Zhao, Lijun Zhang, Shuo Li, Jie Liu, Qi Huang & Rui Zhou. (2022) Growth-Promoting Effects of Zhenqi Granules on Finishing Pigs. Animals 12:24, pages 3521.
Crossref
Haichuan Wang, Yi Zhou, Hongwei Xu, Xue Wang, Yi Zhang, Runze Shang, Marie O'Farrell, Stephanie Roessler, Carsten Sticht, Andreas Stahl, Matthias Evert, Diego F. Calvisi, Yong Zeng & Xin Chen. (2022) Therapeutic efficacy of FASN inhibition in preclinical models of HCC. Hepatology 76:4, pages 951-966.
Crossref
Peng Zhu, Feng Zhang, Weijie Deng & Wenbiao Chen. (2022) Integrative analysis of the characteristic of lipid metabolism-related genes for the prognostic prediction of hepatocellular carcinoma. Medicine 101:39, pages e30695.
Crossref
Jonathan M. Hazlehurst, Teegan Reina Lim, Catriona Charlton, Jack J. Miller, Laura L. Gathercole, Thomas Cornfield, Nikolaos Nikolaou, Shelley E. Harris, Ahmad Moolla, Nantia Othonos, Lisa C. Heather, Thomas Marjot, Damian J. Tyler, Carolyn Carr, Leanne Hodson, Jane McKeating & Jeremy W. Tomlinson. (2022) Acute intermittent hypoxia drives hepatic de novo lipogenesis in humans and rodents. Metabolism Open 14, pages 100177.
Crossref
Hsiu-Lung Fan, Shu-Ting Liu, Yung-Lung Chang, Yi-Lin Chiu, Shih-Ming Huang & Teng-Wei Chen. (2022) In Vitro Cell Density Determines the Sensitivity of Hepatocarcinoma Cells to Ascorbate. Frontiers in Oncology 12.
Crossref
Catherine Yujia Gu & Terence Kin Wah Lee. (2022) Preclinical mouse models of hepatocellular carcinoma: An overview and update. Experimental Cell Research 412:2, pages 113042.
Crossref
Yi Zhou, Junyan Tao, Diego F. Calvisi & Xin Chen. (2021) Role of Lipogenesis Rewiring in Hepatocellular Carcinoma. Seminars in Liver Disease 42:01, pages 077-086.
Crossref
Elisabeth M. Haberl, Rebekka Pohl, Lisa Rein-Fischboeck, Marcus Höring, Sabrina Krautbauer, Gerhard Liebisch & Christa Buechler. (2021) Accumulation of cholesterol, triglycerides and ceramides in hepatocellular carcinomas of diethylnitrosamine injected mice. Lipids in Health and Disease 20:1.
Crossref
Chaofan Fan, Shing Kam & Pierluigi Ramadori. (2021) Metabolism-Associated Epigenetic and Immunoepigenetic Reprogramming in Liver Cancer. Cancers 13:20, pages 5250.
Crossref
Napaporn Khuanphram, Sirinya Taya, Prachya Kongtawelert & Rawiwan Wongpoomchai. (2021) Sesame Extract Promotes Chemopreventive Effect of Hesperidin on Early Phase of Diethylnitrosamine-Initiated Hepatocarcinogenesis in Rats. Pharmaceutics 13:10, pages 1687.
Crossref
Andrea Reszegi, Katalin Karászi, Gábor Tóth, Kristóf Rada, Lóránd Váncza, Lilla Turiák, Zsuzsa Schaff, András Kiss, László Szilák, Gábor Szabó, Gábor Petővári, Anna Sebestyén, Katalin Dezső, Eszter Regős, Péter Tátrai, Kornélia Baghy & Ilona Kovalszky. (2021) Overexpression of Human Syndecan-1 Protects against the Diethylnitrosamine-Induced Hepatocarcinogenesis in Mice. Cancers 13:7, pages 1548.
Crossref
Benjamin Buchard, Camille Teilhet, Natali Abeywickrama Samarakoon, Sylvie Massoulier, Juliette Joubert-Zakeyh, Corinne Blouin, Christelle Reynes, Robert Sabatier, Anne-Sophie Biesse-Martin, Marie-Paule Vasson, Armando Abergel & Aicha Demidem. (2021) Two Metabolomics Phenotypes of Human Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver Disease According to Fibrosis Severity. Metabolites 11:1, pages 54.
Crossref
Joshua K. Park, Nathan J. Coffey, Aaron Limoges & Anne Le. 2021. The Heterogeneity of Cancer Metabolism. The Heterogeneity of Cancer Metabolism 39 56 .
Elisabeth M. Haberl, Rebekka Pohl, Lisa Rein-Fischboeck, Marcus Höring, Sabrina Krautbauer, Gerhard Liebisch & Christa Buechler. (2020) Hepatic lipid profile in mice fed a choline-deficient, low-methionine diet resembles human non-alcoholic fatty liver disease. Lipids in Health and Disease 19:1.
Crossref
Jiaoyuan Jia, Li Che, Antonio Cigliano, Xue Wang, Graziella Peitta, Junyan Tao, Sheng Zhong, Silvia Ribback, Matthias Evert, Xin Chen & Diego F. Calvisi. (2020) Pivotal Role of Fatty Acid Synthase in c-MYC Driven Hepatocarcinogenesis. International Journal of Molecular Sciences 21:22, pages 8467.
Crossref
Marina Serra, Amedeo Columbano, Andrea Perra & Marta Anna Kowalik. (2020) Animal Models: A Useful Tool to Unveil Metabolic Changes in Hepatocellular Carcinoma. Cancers 12:11, pages 3318.
Crossref
Christoph Metzendorf, Katharina Wineberger, Jenny Rausch, Antonio Cigliano, Kristin Peters, Baodong Sun, Daniela Mennerich, Thomas Kietzmann, Diego F. Calvisi, Frank Dombrowski & Silvia Ribback. (2020) Transcriptomic and Proteomic Analysis of Clear Cell Foci (CCF) in the Human Non-Cirrhotic Liver Identifies Several Differentially Expressed Genes and Proteins with Functions in Cancer Cell Biology and Glycogen Metabolism. Molecules 25:18, pages 4141.
Crossref
Jun Li, Liang Li, Yang Lv, Hao Zou, Yanping Wei, Fei Nie, Wanli Duan, Maidinamu Sedike, Liang Xiao & Mei Wang. (2020) The construction of the novel magnetic prodrug Fe 3 O 4 @DOX and its antagonistic effects on hepatocarcinoma with low toxicity . RSC Advances 10:48, pages 28965-28974.
Crossref
Bo Hu, Jian‐Zhen Lin, Xiao‐Bo Yang & Xin‐Ting Sang. (2020) The roles of mutated SWI/SNF complexes in the initiation and development of hepatocellular carcinoma and its regulatory effect on the immune system: A review. Cell Proliferation 53:4.
Crossref
Li Che, Wenna Chi, Yu Qiao, Jie Zhang, Xinhua Song, Ye Liu, Lei Li, Jiaoyuan Jia, Maria G Pilo, Jingxiao Wang, Antonio Cigliano, Zhilong Ma, Wenhua Kuang, Zefang Tang, Zemin Zhang, Guanghou Shui, Silvia Ribback, Frank Dombrowski, Matthias Evert, Rosa Maria Pascale, Carla Cossu, Giovanni Mario Pes, Timothy F Osborne, Diego F Calvisi, Xin Chen & Ligong Chen. (2020) Cholesterol biosynthesis supports the growth of hepatocarcinoma lesions depleted of fatty acid synthase in mice and humans. Gut 69:1, pages 177-186.
Crossref
Li Che, Panagiotis Paliogiannis, Antonio Cigliano, Maria G. Pilo, Xin Chen & Diego F. Calvisi. (2019) Pathogenetic, Prognostic, and Therapeutic Role of Fatty Acid Synthase in Human Hepatocellular Carcinoma. Frontiers in Oncology 9.
Crossref
Desterke & Chiappini. (2019) Lipid Related Genes Altered in NASH Connect Inflammation in Liver Pathogenesis Progression to HCC: A Canonical Pathway. International Journal of Molecular Sciences 20:22, pages 5594.
Crossref
Damian Jacenik, Ellen J Beswick, Wanda M Krajewska & Eric R Prossnitz. (2019) G protein-coupled estrogen receptor in colon function, immune regulation and carcinogenesis. World Journal of Gastroenterology 25:30, pages 4092-4104.
Crossref
Derek J. Erstad, Allen A. Razavi, Shen Li, Kenneth K. Tanabe & Bryan C. Fuchs. 2019. Hepatocellular Carcinoma. Hepatocellular Carcinoma 255 289 .
Serena De Matteis, Andrea Ragusa, Giorgia Marisi, Stefania De Domenico, Andrea Casadei Gardini, Massimiliano Bonafè & Anna Maria Giudetti. (2018) Aberrant Metabolism in Hepatocellular Carcinoma Provides Diagnostic and Therapeutic Opportunities. Oxidative Medicine and Cellular Longevity 2018, pages 1-13.
Crossref
Xiang Wang. (2017) Down‐regulation of lncRNA‐NEAT1 alleviated the non‐alcoholic fatty liver disease via mTOR/S6K1 signaling pathway. Journal of Cellular Biochemistry 119:2, pages 1567-1574.
Crossref
Joshua K. Park, Nathan J. Coffey, Aaron Limoges & Anne Le. 2018. The Heterogeneity of Cancer Metabolism. The Heterogeneity of Cancer Metabolism 33 55 .
Feihong Deng, Yuan Fang, Zhiyong Shen, Wei Gong, Tao Liu, Jing Wen, Wanling Zhang, Xianjun Zhu, Hui Zhong, Tong Wang, Fachao Zhi & Biao Nie. (2017) Use of confocal laser endomicroscopy with a fluorescently labeled fatty acid to diagnose colorectal neoplasms. Oncotarget 8:35, pages 58934-58947.
Crossref
Antonio Cigliano, Chunmei Wang, Maria G. Pilo, Marta Szydlowska, Stefania Brozzetti, Gavinella Latte, Giovanni M. Pes, Rosa M. Pascale, Maria A. Seddaiu, Gianpaolo Vidili, Silvia Ribback, Frank Dombrowski, Matthias Evert, Xin Chen & Diego F. Calvisi. (2017) Inhibition of HSF1 suppresses the growth of hepatocarcinoma cell lines in vitro and AKT-driven hepatocarcinogenesis in mice . Oncotarget 8:33, pages 54149-54159.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.